Clinical trials
Recruiting Breast Neoplasms trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 3 |
| Chinese University of Hong Kong | 2 |
| Olema Pharmaceuticals, Inc. | 2 |
| AstraZeneca | 1 |
| Hoffmann-La Roche | 1 |
| Monash University | 1 |
| NRG Oncology | 1 |
| Novartis Pharmaceuticals | 1 |
| ORIC Pharmaceuticals | 1 |
| Relay Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 17 |
| Breast Neoplasms, Male | 2 |
| Carcinoma, Intraductal, Noninfiltrating | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Neoplasm Metastasis | 1 |
| Postoperative Pain | 1 |
| Triple Negative Breast Neoplasms | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.